Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels
Mol Ther Oncolytics
.
2022 Nov 16:27:203.
doi: 10.1016/j.omto.2022.10.008.
eCollection 2022 Dec 15.
Author
Haili Qian
1
Affiliation
1
State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
PMID:
36420305
PMCID:
PMC9676184
DOI:
10.1016/j.omto.2022.10.008
No abstract available
Keywords:
ESCC; MEK1/2; azelnidipine; drug library; recurrence.
Publication types
Editorial